AI ScreeningAI ChatPricing
  1. US-listed companies
  2. Regenicin, Inc.
  3. Financials
  4. Operating expenses

Regenicin, Inc.【RGIN】

Market cap
$15.35K
P/E ratio
SummaryFinancials
Period EndOperating expenses (Million USD)YoY (%)
Sep 30, 20211+26.91%
Sep 30, 20201-9.88%
Sep 30, 20191-6.66%
Sep 30, 20181-19.16%
Sep 30, 20171-18.38%
Sep 30, 20161+394.54%
Sep 30, 20150-66.69%
Sep 30, 20141-93.48%
Sep 30, 201311+56.01%
Sep 30, 20127+62.31%
Sep 30, 20114

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)